A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge
Article
[키워드] E. coli , Escherichia coli
ANOVA, one-way Analysis of Variance
CFA, complete Freund's adjuvant
CLPEI, disulfide-crosslinked low molecular linear polyethyleneimine
CpG, cytosine-phosphate-guanine
Ct, threshold cycle value
DNA-prime protein-boost regimen
DPH, DNA, polyethyleneimine, and sodium hyaluronate complex
dpi, days post inoculation
E, Envelope
EID50, median embryo infectious dose
GM-CSF, granulocyte-macrophage colony-stimulating factor
HA, hyaluronate
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffered saline
HRP, horseradish peroxidase
IBDV, infectious bursal disease virus
IBV, infectious bronchitis virus
IFA, imnunofluorescent antibody assay
Kb, kilobase
kDa, kilodalton
LB, lysogeny broth
M, membrane
MHV, mouse hepatitis virus
N, nucleocapsid
neutralizing epitopes
NTC, non-template control
OD 450 nm, optical density at 450 nm
Polyethyleneimine
qRT-PCR, quantitative real-time reverse transcription-polymerase chain reaction
S, spike
SARS-CoV, severe acute respiratory syndrome-coronavirus
Spike protein
TCoV, turkey coronavirus
Turkey coronavirus
VN, virus neutralization
[DOI] 10.1016/j.vetimm.2013.01.009 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.vetimm.2013.01.009 PMC 바로가기 [Article Type] Article